Figure 5From: Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies Poorly enhancing cervical tumour indicating poor response to treatment. Pre-treatment sagittal T2 MRI showing a tumour in the posterior cervical lip (a), at the end of treatment there is recurrent disease (b) and 6Â months later residual disease is present (c). The pre-treatment DCE images are shown in figures d-g from pre-contrast to later contrast enhancement, minimal enhancement of the tumour is seen predicting the poor outcome to treatment observed.Back to article page